Just In
- 1 hr ago Mahavir Jayanti 2024: Date, Time, History, Celebrations And Teachings Of Lord Mahavir In Jainism
- 2 hrs ago Parineeti Chopra Saree Looks: Check Amar Singh Chamkila Actor's Regal Fashion Statements
- 4 hrs ago Vidya Balan's 'Do Aur Do Pyaar' Urban Boho Style Avatar Is Relatable And Inspiring, Check Her Modern Avatar!
- 12 hrs ago Golden Rules To Follow For Happy Marriage For A Long Lasting Relationship
Don't Miss
- Sports Manchester City vs Chelsea, FA Cup: Preview, Team News, Predicted Lineup, H2H
- News Neha Hiremath Murder Case: Accused Fayaz's Father Apologises, Says Give My Son The Most Severe Punishment
- Finance Portfolio Management Services PMS vs. Mutual Funds: Detail Analysis
- Movies Metro In Dino: When Ananya Panday Warns Sara Ali Khan Not To Touch Aditya Roy Kapur As She Pairs Up With Him
- Technology Garena Free Fire Max Redeem Codes for April 20, 2024: Get Access to the Latest In-game Loot
- Automobiles Ford Mustang 60th Anniversary Package – Limited To Just 1,965 Units
- Education Exam Pressure Does Not Exist; Studying Punctually is Crucial; Says Aditi, the PSEB 2024 Topper
- Travel Journey From Delhi To Ooty: Top Transport Options And Attractions
Government Allows Serum Institute To Export 50 Lakh Covishield Doses Under Covax To 4 Nations
The Union government has allowed the Serum Institute of India to export 50 lakh doses of COVID-19 vaccine Covishield under the UN-backed COVAX global vaccine programme to Nepal, Tajikistan and Mozambique, official sources said on Sunday.
In addition to these three countries, the SII will also export Covishield to Bangladesh under COVAX, they said.
The SII will commence Covid vaccine export under the COVAX programme from November 23 and Nepal will receive the first lot of Covishield on November 24.
The government, earlier in October, had permitted the SII to export 10 lakh Covishield doses each to Nepal, Myanmar and Bangladesh under the 'Vaccine Maitri' programme.
In a recent communication to the Union Health Ministry, Prakash Kumar Singh, Director, Government and Regulatory Affairs at Serum Institute of India (SII) is learnt to have informed that the Pune-based firm has manufactured stock of 24,89,15,000 doses of Covishield and that the stock is increasing day by day.
- wellnessCervical Cancer Vaccine: All You Need To Know About India's Self-Developed HPV Vaccine
- wellnessDCGI Approves India's First qHPV Vaccine Against Cervical Cancer
- kidsSerum Institute Seeks Covovax's Inclusion In Covid Vaccination Drive For 12 Years And Over
- wellnessDCGI Grants Emergency Use Authorisation To Covovax For 12-17 Years Age Group; Younger Age Groups To Follow
- healthReduce Gap Between 2nd Dose And Precaution Dose Of Covishield, Urges Serum Institute To Health Ministry
- healthSerum Institute CEO Hails WHO's Approval Of Covovax For Emergency Use
- healthSerum Institute Urges Govt To Fast-Track Movement Of Increasing Covishield Stock
- healthCOVID-19 Vaccines and Heart Attacks: New Studies Show Different Results; What Are They?
- wellnessCorbevax Will Be Allowed As A Booster For Those Fully Vaccinated With Covishield Or Covaxin
- wellnessBooster Dose Of COVID Vaccine Needed To Fight Against Omicron: Study
- wellnessCovishield Dose Gap Reduced To 8-16 Weeks From 12-16
- healthEach Dose Of Covishield, Covaxin Likely To Be Capped At Rs 275 After Getting Regular Market Approval